ImmunoGen Inc (IMGN)

[skitahoe]

It has hit $7.15, let's see how close to the high it is at the close. Frankly, it really doesn't matter precisely what we do today, what matters is the results which should be revealed as we go into the end of the year, and in follow on years.

In 2015 our high was $13+ as I remember it. I believe the company is much further along right now, and it will only get better if trial results on our new IGN drugs are even more promising than those using the DMx effector molecules, and we should see some initial results later this year.

While in near term I'm looking to see new annual highs, I believe that with positive news in the conferences late in the calendar year, we should see highs that haven't been seen for over 3 years. We're still a couple years from setting new all time highs, somewhere over $40, but it's possible before the next drug approval provided other products also are advancing toward approval as well.

The joker in the deck, that could change things dramatically in an instant, would be IMGN completing one or more partnerships for wholly owned drugs that permit IMGN to keep North America for itself, while providing ROW rights to a partner who will pay substantial money up front, and royalties on ROW sales. No telling when such a partnership will occur, but IMGN has said that's what they want and I believe they'll achieve it as more positive clinical data is revealed.

Gary